Æ-941, an inhibitor of angiogenesis:: Rationale for a phase III study on Æ-941 in combination with induction chemotherapy/radiotherapy in patients with non small cell lung cancer (NSCLC).
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- November 1999
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Clinical Cancer Research Journal